Identification of Human Cutaneous Basal Cell Carcinoma Cancer Stem Cells
The cancer stem cell model states that a subset of tumor cells, called “cancer stem cells,” can initiate and propagate tumor growth through self-renewal, high proliferative capacity, and their ability to recreate tumor heterogeneity. In basal cell carcinoma (BCC), we have shown that tumor cells that express the cell surface protein CD200 fulfill the cancer stem cell hypothesis. CD200+ CD45− BCC cells represent 0.05–3.96% of all BCC cells and reside in small clusters at the tumor periphery. Using a novel, reproducible in vivo xenograft growth assay, we determined that tumor-initiating cell (TIC) frequencies are approximately 1 per 1.5 million unsorted BCC cells. The CD200+ CD45− BCC subpopulation recreated BCC tumor growth in vivo with typical histological architecture and expression of sonic hedgehog-regulated genes. Reproducible in vivo BCC growth was achieved with as few as 10,000 CD200+ CD45− cells, representing ~1500-fold enrichment. The methods used to identify and purify CD200+ CD45− BCC cells, as well as characterize gene expression, are described herein.
KeywordsBasal cell carcinoma Cancer stem cells Mouse models Skin cancer Tumor-initiating cells
This work is supported by grants from Cancer Research Wales, Cancer Research UK, and Hywel Dda University Health Board.
- 1.Morgan H, Benketah A, Ord-McDermott L, Rees E, Mukhtar A, Lanfredini S, Olivero C, Patel GK (2018) Hair follicle telogen differentiation in human basal cell carcinoma. (Manuscript submitted)Google Scholar